Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study for effects of Masport in adults with glabellar facial lines
IRCT201201154536N2Phase 2Completed
- Sponsor
- Masoon Darou
- Start
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of abobotulinumtoxinA in glabellar furrowing, sponsored by Masoon Darou. Started Apr 2012; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on IRCT201201154536N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201201154536N2.